Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Epazz, Inc.: Galaxy Batteries, Inc. Unveils Manufacturing Site to Spearhead Solid-State Battery Technology
-
Odysight.ai Announces 2023 Financial Results and Provides Corporate Update
-
SeaStar Medical to Restate Financials, Sets Business Update Call for April 17
-
NEW SCIENTIFIC PUBLICATION SHOWS LB-100, LIXTE’S LEAD CLINICAL COMPOUND, CAN FORCE CANCER CELLS TO GIVE UP THEIR CANCER-CAUSING PROPERTIES
-
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024
-
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors
-
LM Funding Regains Compliance with Nasdaq Continued Listing Requirements
-
Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium
-
Building Supplies Retailer Chooses Bridgeline for AI-Powered Search
-
Wave Life Sciences to Present at Upcoming Investor Conferences
-
Dyadic to Attend Industry Events in April
-
LiveOne (NASDAQ: LVO) Hosts Event Celebrating Women in the Entertainment Industry
-
Core Specialty Leads the Way in Innovation with Duck Creek's Cloud-based SaaS Solutions via Microsoft Azure Marketplace
-
Allarity Therapeutics Makes Strategic Pivot to Focus Solely on Accelerating Stenoparib Toward Regulatory Approval in Advanced Recurrent Ovarian Cancer
-
Bridges Consumer Healthcare Appoints John Speranza as New CEO
-
Dimensional Fund Advisors Ltd. : Form 8.3 - UK COMMERCIAL PROPERTY REIT - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - TRITAX BIG BOX REIT PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares
-
Markham Fertility Centre and humm Canada partner to make fertility treatments more accessible
-
South Korea's Leading Adult Education Company, Fast Campus, Intensifies Its Foray into the US Market with New Business Ventures
-
South Korea's Leading Adult Education Company, Fast Campus, Intensifies Its Foray into the US Market with New Business Ventures
-
Aslan Pharmaceuticals to Present at the 2nd Annual H.C. Wainwright Autoimmune and Inflammatory Disease Virtual Conference: Skin Diseases, Conditions and Disorders
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares
-
Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone
-
Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium
-
Avicanna Announces the Canadian Launch of 10% CBD (THC Free) Proprietary Formulation
-
Cumulus Media Announces Extension of Expiration Time in Exchange Offer and Consent Solicitation Relating to 6.750% Senior Secured First-Lien Notes due 2026
-
UniFirst Announces Financial Results for the Second Quarter of Fiscal 2024
-
Vizit and Salsify Partner to Deliver AI-Powered Conversion Optimizer Application, Elevating Ecommerce Sales to New Heights
-
Form 8.3 - [SPIRENT COMMUNICATIONS PLC - 26 03 2024] - (CGAML)
-
Dynatron Software and NCM Associates Partner On New Fixed Operations Focused 20 Groups
-
Drilling Underway at Red Mountain Project
-
ProStar Holdings Announces Closing of First Tranche of Private Placement for Gross Proceeds of US$1 Million
-
CanStays Rental Alliance to Convene Federal Minister Leblanc, Alberta Minister Schow, and Major Industry Players to Discuss Short-Term Rentals
-
Pixalate's February 2024 Global Mobile Publisher Trust Index for Apple App Store and Google Play Store: ESPN Ranks as No. 1 Open Programmatic Ad-Supported App in North America on Apple
-
SaverOne Signs Milestone OEM Agreement with IVECO
-
brooqLy Launches Operations in Sub-Saharan Africa with MrExportToAfrica
-
Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the Middle East and North Africa
-
Vocodia Holdings’ AI Technology Featured in USA Today
-
PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors
-
Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies
-
Over 70% of Retailers Lose at Least 5% Operating Margin to In-Store Inefficiencies, According to New Study from Coresight Research and Simbe
-
Tellbio’s Technology Demonstrates that Analysis of Circulating Tumor Cells Can Predict Survival Among Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Radium-2230
-
Ladybug Resource Group Continues to Strive Toward $25 Million 2024 Revenue Goal.
-
Construction employment growth in Alberta to 2033 is driven by strong non-residential demands
-
Clubhouse Media Group, Inc. Reports 2023 Financial Results, Highlighting Increased Revenue and Decreased Expenses
-
Global Commercial Real Estate Brand SVN® Appoints New Healthcare Product Council Co-Chair
-
Plus Therapeutics to Present at the National Comprehensive Cancer Network Annual Conference
-
Sono-Tek to Present at The LD Micro Invitational XIV
-
One Biosciences Welcomes Dr. Scott Braunstein and Dr. Vincent Miller to its Board of Directors
